The 9th to 17th "Immunological Diseases Series Academic Conferences & Confluence · Multidisciplinary Medical Treatment Exchange Meetings" were successfully held online and offline from November 5 to December 16, 2025. This series of academic conferences aimed to establish a professional, standardized, and innovative high-level academic exchange platform for healthcare professionals in the field of immunological diseases and related disciplines. Through multidisciplinary collaboration and integration, it sought to advance clinical research and significantly improve clinical diagnosis and treatment standards across various disease domains. Adhering to the core principles of "focusing on clinical practice, emphasizing practicality, keeping pace with cutting-edge developments, and addressing key issues," the conferences concentrated on critical diagnostic and therapeutic challenges in specialized diseases. Carefully designed segments such as cutting-edge guideline interpretation, case presentations, and clinical experience sharing ensured the content was both academically rigorous and practically valuable.

This conference covers a wide range of disciplines, spanning multiple fields closely related to immune diseases, including cardiology, nephrology, respiratory medicine, endocrinology, neurology, dermatology, rheumatology, and hematology. The sessions will delve into the latest diagnostic and treatment protocols, clinical pathway optimizations, and cutting-edge research advancements for various common and frequently encountered immune-related conditions. Attendees will experience a multidisciplinary academic feast.

The diagnosis and treatment of immune diseases involve multiple systems and interdisciplinary collaboration. The organization of this series of academic conferences will effectively promote academic exchanges and technical cooperation among various disciplines, helping medical professionals stay updated on industry advancements, refine diagnostic and therapeutic concepts, and enhance clinical skills. By convening this conference, we aim to further consolidate industry expertise and contribute actively to the standardized development and discipline-building in the field of immune disease diagnosis and treatment in China.